{
    "nctId": "NCT03347864",
    "briefTitle": "68Ga-NOTA-RM26 PET/CT in Breast Tumor Patients",
    "officialTitle": "Diagnostic Performance of 68Gallium-labeled NOTA-RM26 PET/CT in Breast Tumor Patients",
    "overallStatus": "UNKNOWN",
    "conditions": "Breast Tumor",
    "studyType": "INTERVENTIONAL",
    "phase": "EARLY_PHASE1",
    "allocation": "NA",
    "primaryPurpose": "DIAGNOSTIC",
    "enrollmentCount": 30,
    "primaryOutcomeMeasure": "Standardized uptake value of 68Ga-NOTA-RM26 in breast tumor",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* patients in suspicion of breast cancer by mammography or ultrasonography,and being able to provide basic information and sign the written informed consent form\n\nExclusion Criteria:\n\n* The exclusion criteria included claustrophobia, pregnancy, breastfeeding, kidney or liver failure, inability to fulfill the study, and undergoing any preceding local or systemic therapies that might interfere with GRPR binding",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}